Authors:
List, AF
Kopecky, KJ
Willman, CL
Head, DR
Persons, DL
Slovak, ML
Dorr, R
Karanes, C
Hynes, HE
Doroshow, JH
Shurafa, M
Appelbaum, FR
Citation: Af. List et al., Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study, BLOOD, 98(12), 2001, pp. 3212-3220
Authors:
Cui, W
Yazlovitskaya, EM
Mayo, MS
Pelling, JC
Persons, DL
Citation: W. Cui et al., Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistantovarian carcinoma cell lines, MOL CARCINO, 29(4), 2000, pp. 219-228
Authors:
Persons, DL
Arber, DA
Sosman, JA
Borelli, KA
Slovak, ML
Citation: Dl. Persons et al., Amplification and overexpression of HER-2/neu are uncommon in advanced stage melanoma, ANTICANC R, 20(3B), 2000, pp. 1965-1968
Authors:
Persons, DL
Bui, MM
Lowery, MC
Mark, HFL
Yung, JF
Birkmeier, JM
Wong, EY
Yang, SJ
Masood, S
Citation: Dl. Persons et al., Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: A multicenter portability study, ANN CLIN L, 30(1), 2000, pp. 41-48
Authors:
Persons, DL
Yazlovitskaya, EM
Pelling, JC
Citation: Dl. Persons et al., Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin, J BIOL CHEM, 275(46), 2000, pp. 35778-35785
Authors:
Persons, DL
Yazlovitskaya, EM
Cui, W
Pelling, JC
Citation: Dl. Persons et al., Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: Inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin, CLIN CANC R, 5(5), 1999, pp. 1007-1014
Authors:
Yazlovitskaya, EM
Pelling, JC
Persons, DL
Citation: Em. Yazlovitskaya et al., Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101, MOL CARCINO, 25(1), 1999, pp. 14-20